Pancreatic cancer
Results
Phase 2
This study looked at having a drug called GDC-0449 before surgery to remove cancer of the pancreas. It was for people who have the most common type of pancreatic cancer called adenocarcinoma.
Recruitment start: 14 February 2011
Recruitment end: 9 August 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor D Tuveson
Cambridge University Hospitals NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
Roche-Genentech
NIHR Clinical Research Network: Cancer
Last reviewed: 19 May 2016
CRUK internal database number: 7994
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
